INS and prostate carcinoma: For example, a special serum-free defined medium that can support short-term, long-term, and clonal growth of the human prostatic carcinoma cell lines LNCaP, DU 145, PC-3, and ALVA-31 must contain insulin (Hedlund and Miller, 1994).